Amazon has been reinforcing its HIPAA-compliant offerings so that health-care providers and insurers can save and transfer customer data.
Credit Suisse lowered both its rating and price target on Pfizer's stock as expiring patents will weigh on earnings.
Abbott will report second-quarter numbers on Thursday as it completes the Alere deal. $ABT $ALR
Vertex Pharmaceuticals, FibroGen and Inovio Pharmaceuticals were among the biotech stock movers in premarket trading trading on July 19.
Shares of Johnson & Johnson post-earnings are rumbling towards a major breakout.
Puma Biotechnology, Nektar Therapeutics and Paratek Pharmaceuticals were among the biotech movers in premarket trading on July 18.
Wait a few days before buying Johnson & Johnson.
FDA Commissioner Dr. Scott Gottlieb's main goals in bringing more affordable drugs to market is by taking aim at the distribution process.
Medtronic is still working to fill back orders.
NKTR-181 is the first full mu-opioid agonist molecule designed to provide potent pain relief without the high levels of euphoria that can lead to abuse and addiction with standard opioids.